Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Patent
1994-04-22
2000-03-28
Eisenschenk, Frank C.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
4241841, 4242041, 424 936, 424819, 435 691, 435 693, 4353201, 4352351, A61K 3921, A61K 3912, A01N 6300, C12P 2106
Patent
active
06042835&
ABSTRACT:
Molecular clones of feline leukemia virus isolates that encode (a) a prototype highly infectious, minimally pathogenic virus, (b) a variant genome that is replication-defective and associated with a fatal immunodeficiency in cats similar to AIDS (FAIDS) or (c) a chimeric genome that is replication-competent and induces FAIDS. These molecular clones may be used to generate cell lines producing infectious virus which is useful in the preparation of vaccines or in the generation of viremia or disease challenge systems.
REFERENCES:
patent: 3966907 (1976-06-01), Jarrett et al.
patent: 4034081 (1977-07-01), Jarrett et al.
patent: 4086134 (1978-04-01), Jarrett et al.
patent: 4117112 (1978-09-01), Jarrett et al.
patent: 4264587 (1981-04-01), Pedersen et al.
patent: 4332793 (1982-06-01), Olson
patent: 4405712 (1983-09-01), Vande Woude et al.
patent: 4406885 (1983-09-01), Pinter
patent: 4434157 (1984-02-01), Olsen
patent: 4593002 (1986-06-01), Dulbecco
patent: 4663436 (1987-05-01), Elder et al.
patent: 4699785 (1987-10-01), Pedersen
patent: 4701416 (1987-10-01), Nunberg
patent: 4734362 (1988-03-01), Hung et al.
patent: 4748234 (1988-05-01), Dorin et al.
patent: 4789702 (1988-12-01), Nunberg
patent: 4794168 (1988-12-01), Elder et al.
patent: 4876089 (1989-10-01), Lucjw et al.
patent: 5306493 (1994-04-01), Kelsey
Hoover, Edward A. et al. "Protection against feline leukemia virus infection by use of an inactivated virus vaccine," JAVMA 199(10):1392-1401.
Hoover, Edward A. et al. "Experimental Transmission and Pathogenesis of Immunodeficiency Syndrome in Cats," Blood 70(6):1880-1892, 1987.
Stewart, Monica A. et al. "Nucleotide Sequences of a Feline Leukemia Virus Subgroup A Envelope Gene and Long Terminal Repeat and Evidence for the Recombinational Origin of Subgroup B Viruses," Journal of Virology 58(3):825-834, 1986.
Mullins, James I. et al. "Disease-specific and tissue-specific production of unintegrated feline leukaemia virus variant DNA in feline AIDS," Nature 319:333-336, 1986.
Overbaugh, Julie et al. "Molecular Cloning of a Feline Leukemia Virus That Induces Fatal Immunodeficiency Disease in Cats," Science 239:906-910, 1988.
Overbaugh, Julie et al. "Transduction of endogenous envelope genes by feline leukemia virus in vitro," Nature 332:731-734, 1988.
Donahue, Peter R. "Strong Sequence Conservation among Horizontally Transmissible, Minimally Pathogenic Feline Leukemia Viruses," Journal of Virology 62(3):722-731, 1988.
Overbaugh et al. Cold Spring Harbor Laboratory Abstracts of Papers Presented at the 1986 Meeting on RNA Tumor Viruses, May 20-25, 1986, describes variability in feline AIDS virus genomes, p. 141.
Donahue et al. Cold Spring Harbor Laboratory Abstracts of Papers Presented at the 1987 Meeting on RNA Tumor Viruses, May 19-May 24, 1987, describes pathogenic determinants of the feline AIDS virus.
Stewart et al. J. Virology 58(3):825-834, 1986, describes nucleotide sequences of a feline leukemia virus subgroup A envelope gene and long terminal repeat.
Smith, Geoffrey et al. "Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenze hemagglutinin gene and induces resistance to influenze virus infection in hamsters," Proc. Natl. Acad. Sci. 80:7155-7159, 1983.
Chakrabarti, Sekhar et al. "Vaccinia Virus Expression Vector: Coexpression of .beta.-Galactosidase Provides Visual Screening of Recombinant Virus Plaques," Molecular and Cellular Biology 5(12):3403-3409, 1985.
Starcich, Bruno R. et al. "Identification and Characterization of Conserved and Variable Regions in the Envelope Gene of HTLV-III/LAV, the Retrovirus of AIDS," Cell 45:637-648, 1986.
Hahn, Beatrice H. Hahn et al. "Genomic diversity of the acquired immune deficiency syndrome virus HTLV-III: Different viruses exhibit greatest divergence in their envelope genes," Proc. Natl. Acad. Sci. 82:4813-4817, 1985.
Devarc, S.G. et al. "Genomic diversity of the acquired immunodeficiency syndrome retroviruses is reflected in alteration of its translational products," Proc. Natl. Acad. Sci. 83:5718-5722, 1986.
Montelaro, Ronald C. "Antigenic Variation during Persitent Infection by Equine Infectious Anemia Virus, a Retrovirus," The Journal of Biological Chemistry 259(16): 10539-10544, 1984.
Pedersen, N.C. et al. "Possible immunoenhancement of persistent viremia by feline leukemia virus envelope glycoprotein vaccines in challenge-exposure situations where whole inactivated virus vaccines were protective," Veterinary Immunology and Immunopathology 11:123-148, 1986.
Riedel et al. "Evolution of Feline Leukemia Viruses," Cold Spring Harbor Laboratory 1986 Meeting on RNA Tumor Viruses, May 20-May 25, 1986.
Rubsamen-Waigmann, H. "Isolation of Variants of Lymphocytopathic Retroviruses From the Peripheral Blood and Cerebrospinal Fluid of Patients With ARC or AIDS," Journal of Medical Virology 19:335-344, 1986.
Hardy, William D., Jr., et al. "Biology of Feline Leukemia Virus in the Natural Environment," Cancer Research 36:582-588, 1976.
Hahn, Beatrice H. et al. "Genetic Variation in HTLV-III/LAV Over Time in Patients with AIDS or at Risk for AIDS," Science 232:1548-1553, 1986.
Sebring et al. J. Am. Vet. Med. Assoc. 199:1413-1419.
Legendre et al. Am. Vet. Med. Assoc. 199:1456-1462.
Burie et al. Science 247:1306-1310 1990.
Burgess et al. J. Cell Biology 111:2129-38, Nov. 1990.
Cozpr et al. Mol. Cell Biol. 8(3):1247-52, Mar. 1988.
Hoover Edward A.
Mullins James I.
Colorado State University Research Foundation
Eisenschenk Frank C.
Harvard University
Zeman Mary K
LandOfFree
Prototype FelV isolates for use in disease models and vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prototype FelV isolates for use in disease models and vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prototype FelV isolates for use in disease models and vaccines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1323777